Page results
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 29 January 2025.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain and spine. This treatment may also be referred to as whole central nervous system (CNS) or cranio-spinal radiotherapy.
-
This page offers advice to patients who are feeling sick.
-
This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.
-
Update about our hospital on Gray's Inn Road
File results
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0605 - Finance software system/ installation and expiry of software
-
FOI/2024/0597 - Urothelial cancer treatments
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments